Diabetes technology

Continuous Glucose Monitoring With Geriatric Principles in Older Adults With Type 1 Diabetes and Hypoglycemia: A Randomized Controlled Trial

Diabetes CarePublished Randomised controlled trial

Primary result · Change in hypoglycemia (time <70 mg/dL)Result — go to the resultMedian difference −2.3% 95% CI −3.7% to −1.3%

Authors' conclusion

In older adults with T1D and high risk of hypoglycemia, CGM use enhanced by geriatric principles can lower hypoglycemia without worsening glycemic control in a cost-effective fashion.

Study context

Population
Older adults (≥65 years) with T1D and hypoglycemia (≥2 episodes of blood glucose <70 mg/dL for ≥20 min over 2 weeks), continuous glucose monitoring (CGM) naive or CGM users; aged 71 ± 5 years, 21% ≥75 yearsrandomized
Participants
131 adults
Comparison
CGM with geriatric principles vs usual care
  • Interventionn = 68
  • Controln = 63reference
Primary endpoint
Change in time with blood glucose <70 mg/dL
Follow-up
Baseline to 6 months

Primary result

Change in hypoglycemia (time <70 mg/dL)

Median difference

−2.3%

95% CI −3.7% to −1.3%

P < 0.001

Change by group

Intervention

−2.6%

median

Control

−0.3%

median

Interventionvs Control
median difference −2.3% (95% CI −3.7% to −1.3%); P < 0.001

As reported in the abstract

Further findings

Change in hypoglycemia, subgroups by prior CGM use · baseline to 6 months

CGM naive
−2.8% (95% CI −5.6%, −0.8%)
CGM users
−1.2% (95% CI −2.7%, −0.1%)

HbA1c

HbA1c did not differ between the groups

Cost-effectiveness (health care sector perspective)

Incremental cost-effectiveness ratio, intervention
$71,623 per quality adjusted life-year

Original publication

Continuous Glucose Monitoring With Geriatric Principles in Older Adults With Type 1 Diabetes and Hypoglycemia: A Randomized Controlled Trial. Diabetes Care. Published 26 September 2024. doi:10.2337/dc24-1069

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.